英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
encoded查看 encoded 在百度字典中的解释百度英翻中〔查看〕
encoded查看 encoded 在Google字典中的解释Google英翻中〔查看〕
encoded查看 encoded 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Encoded Therapeutics – Translating Next-Generation Science into . . .
    Disorders of the central nervous system contribute to premature mortality and lifelong disability in children and adults globally Encoded is developing genetic medicines designed to address the root cause of CNS disorders and deliver potentially long-lasting and life-changing benefits
  • News – Encoded Therapeutics
    News Events Press Releases May 13, 2025 Encoded Therapeutics Presents Promising New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting April 28, 2025 Encoded Therapeutics to Present New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting February 13, 2025
  • Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy . . .
    Encoded has aligned with FDA and MHRA on the design of a sham-controlled, delayed-treatment, potentially confirmatory trial ETX101 has Fast Track, Rare Pediatric, and Orphan Drug Designations from FDA and Orphan Designation from EMA
  • ETX101 for Dravet Syndrome – Encoded Therapeutics
    Encoded is developing ETX101, a potential one-time, disease-modifying gene regulation therapy for SCN1A+ Dravet syndrome ETX101, Encoded’s lead program, is specifically designed to address the underlying cause of Dravet syndrome, the most common developmental and epileptic encephalopathy
  • About – Encoded Therapeutics
    Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients Our diversity – whether gender, ethnicity, sexual orientation, religion, age or disability – is one of our biggest strengths as an organization
  • Programs – Encoded Therapeutics
    Programs Encoded is building an internally developed pipeline of best- and potentially first-in-class therapies focused on central nervous system (CNS) disorders
  • Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to . . .
    SOUTH SAN FRANCISCO, Calif – June 26, 2019 – Encoded Therapeutics, Inc (Encoded), a precision gene therapy company, today announced a $104 million Series C financing which will be used to develop and commercialize innovative therapeutics with the potential to transform the treatment paradigm for severe genetic disorders
  • Our Science – Encoded Therapeutics
    The precision gene therapies being developed at Encoded are designed to modulate gene expression within specific cell types to potentially address the underlying disease mechanism
  • Encoded Therapeutics Announces US IND Clearance and Australian CTA . . .
    Encoded has received clearance for its Investigational New Drug (IND) application from the US Food and Drug Administration and approval under the Clinical Trial Approval (CTA) scheme from the Australia Therapeutic Goods Administration to initiate clinical trials of its gene therapy candidate, ETX101
  • Encoded Therapeutics Presents Promising New Data for CNS Gene Therapy . . .
    New data in chronic pain include the first demonstration of preclinical efficacy for Encoded’s SCN9A -targeted vectorized miRNA candidates in a rat pain model, showing a durable analgesic effect and up to 70 percent Scn9a knockdown in DRG tissue





中文字典-英文字典  2005-2009